Yonsei University: Thyroid Neoplasms trials

The registry lists 12 Thyroid Neoplasms studies with Yonsei University as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 2Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Comparison of the Coughing Frequency of Remimazolam Total Intravenous Anesthesia Versus Inhalational AnesthesiaCompletedNCT06275425Not applicable
• The Effects of Deep Neuromuscular Blockade During Robot-assisted Transaxillary Thyroidectomy on Postoperative Pain and Sensory ChangeCompletedNCT03871387Not applicable
• The Effects of Preoperative Prayer on Postoperative Quality of Recovery in Patients Undergoing ThyroidectomyStatus unknownNCT03375931Not applicable
• Effect of Perioperative Intravenous Lidocaine Infusion and Magnesium Infusion on the Functional Recovery After General Anesthesia in the Patients Undergoing Thyroid SurgeryCompletedNCT02018276Not applicable
• An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid CancerCompletedNCT01964144Phase 2
• Effects of Systemic Lidocaine on Postoperative Quality of Recovery After Robot-assisted ThyroidectomyCompletedNCT01907997Not applicable
• Comparison Between Remifentanil Target-controlled Infusion and Dexmedetomidine Bolus Administration for Smooth Emergence From General Sevoflurane AnesthesiaCompletedNCT01617694Not applicable
• Comparative Study of Surgical Completeness After Robotic Thyroidectomy Versus Conventional Open ThyroidectomyCompletedNCT01354639
• Analgesic Efficacy of Bilateral Superficial Cervical Plexus Block in Robot-assisted Endoscopic Thyroidectomy Using a Transaxillary ApproachCompletedNCT01325857Not applicable
• A Comparative Study of Robotic Thyroidectomy Using Transaxillary Approach Versus Conventional Open ThyroidectomyCompletedNCT01311089
• Dose-dependent Effect of Fentanyl on Cough Attenuation During Emergence From General AnaesthesiaCompletedNCT01308320Phase 4
• Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid CancerCompletedNCT01164176Phase 2